MarketCapTrends
MRNA

Moderna, Inc. (MRNA)

NASDAQ · Healthcare

Moderna, Inc. annual/quarterly total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Moderna, Inc. total liabilities for the quarter ending December 31, 2025 were 3.69B, a 13.79% increase year-over-year.
  • Moderna, Inc. total liabilities for 2025 were 3.69B, a 13.79% increase from 2024.
  • Moderna, Inc. total liabilities for 2024 were 3.24B, a 29.11% decrease from 2023.
  • Moderna, Inc. total liabilities for 2023 were 4.57B, a 32.12% decrease from 2022.
  • Moderna, Inc. total liabilities for 2022 were 6.74B.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Moderna, Inc. Annual Total Liabilities (Millions of US $)
2025$3,688
2024$3,241
2023$4,572
2022$6,735
2021$10,524
2020$4,776
2019$415
2018$432
2017$459
Moderna, Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$3,688
2024-12-31$3,241
2023-12-31$4,572
2022-12-31$6,735
2021-12-31$10,524
2020-12-31$4,776
2019-12-31$415
2018-12-31$432
2017-12-31$459

Moderna Inc. Total Liabilities — FAQ

Moderna Inc. (MRNA) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see MRNA's total liabilities history?

The chart and table above show Moderna Inc.'s total liabilities by year and by quarter, including the growth rate.